Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vertex™ Pipette Tips – Range of low-retention tips developed specifically for life science researchers

Published: Tuesday, December 10, 2013
Last Updated: Tuesday, December 10, 2013
Bookmark and Share
SSI has launched a new comprehensive family of pipette tips designed to provide researchers with the highest level of liquid handling performance.

The Vertex™ Pipette Tips were developed following extensive research to provide users with a high degree of fluid confidence and control while pipetting.  SSI internal studies have indicated their tips provide less fluid retention and less sample loss.  All Vertex tips are manufactured using SSI’s specially formulated NoStick® resin.  Through use of this resin, the inner surface of the tip is considerably more hydrophobic than standard industry tips enabling viscous fluids in particular to be dispensed more completely.  The finely tapered tip construction and thinner walls eliminate the need for users to touch off their pipettor.  Researchers maintain more pipetting control in general, but especially when working with smaller volumes.

SSI has produced a short video detailing their new Vertex™ Pipette Tips.  It can be found on their microsite.

The new range of tips includes bulk, racked, sterile, and EcoPac® (refill insert) options.  They are producing Un-Filtered and Filtered varieties in 10µl, 10µlXL, 200µl, 300µl, 1mL and 1250µl sizes.

The Vertex line includes a time-saving EcoPac® Refill System.  The new system does not require any tools or special instructions to enable users to move from an empty insert to a fresh set of 96 tips.  The Vertex racks were uniquely designed for one-hand operation.  A simple press on the front of the lid releases it from the rack; otherwise the lid sits securely closed.  The EcoPac refills provide over a 70% savings in total materials (including products and packaging).


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!